Finally, we directly confirmed that MYC and KRAS oncogenes regulate the interferon and ISG suppression phenotypes in tumor-derived PDAC and OS models using siRNA knockdown of MYC and MEKi treatment. The gene discussed is MYC; the disease is neoplasm.